content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: ORBIMED CAPITAL LLC -->
            <cik>0001157524</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001800315</issuerCik>
        <issuerName>Galecto, Inc.</issuerName>
        <secFileNumber>001-39655</secFileNumber>
        <issuerAddress>
          <com:street1>75 State Street</com:street1>
          <com:street2>Suite 100</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02109</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>45-70-70-52-10</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>The Biotech Growth Trust PLC</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Bank of America</name>
          <address>
            <com:street1>One Bryant Park</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10036</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>14700</noOfUnitsSold>
        <aggregateMarketValue>37485.00</aggregateMarketValue>
        <noOfUnitsOutstanding>25673474</noOfUnitsOutstanding>
        <approxSaleDate>07/13/2023</approxSaleDate>
        <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>09/25/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Private placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>14700</amountOfSecuritiesAcquired>
        <paymentDate>09/25/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>The Biotech Growth Trust PLC</name>
          <address>
            <com:street1>601 Lexington Ave.</com:street1>
            <com:street2>54th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <saleDate>04/14/2023</saleDate>
        <amountOfSecuritiesSold>3133</amountOfSecuritiesSold>
        <grossProceeds>5827.38</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>OrbiMed Capital LLC is the portfolio manager of The Biotech Growth Trust PLC. The Biotech Growth Trust Plc sold 990 shares of Common Stock on April 17, 2023 at a per share price of $1.97 for gross proceeds of $1,950.30.</remarks>
      <noticeSignature>
        <noticeDate>07/13/2023</noticeDate>
        <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, portfolio manager for The Biotech Growth Trust PLC</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3828}]
text: 144
  0001157524
  XXXXXXXX
  LIVE
  0001800315
  Galecto, Inc.
  001-39655
  75 State Street
  Suite 100
  Boston
  MA
  02109
  45-70-70-52-10
  The Biotech Growth Trust PLC
  Shareholder
  Common Stock
  Bank of America
  One Bryant Park
  New York
  NY
  10036
  14700
  37485.00
  25673474
  07/13/2023
  Nasdaq Stock Market
  Common Stock
  09/25/2020
  Private placement
  Issuer
  N
  14700
  09/25/2020
  Cash
  N
  The Biotech Growth Trust PLC
  601 Lexington Ave.
  54th Floor
  New York
  NY
  10022
  Common Stock
  04/14/2023
  3133
  5827.38
  OrbiMed Capital LLC is the portfolio manager of The Biotech Growth Trust PLC. The Biotech Growth Trust Plc sold 990 shares of Common Stock on April 17, 2023 at a per share price of $1.97 for gross proceeds of $1,950.30.
  07/13/2023
  /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, portfolio manager for The Biotech Growth Trust PLC